---
title: News
---

[![Cebreo Medical - Wordmark color](https://cebreomedical.com/hubfs/Cebreo%20Medical%20-%20Wordmark%20color.svg)](https://cebreomedical.com/mainpage?hsLang=en)

- [Scientific Evidence](https://cebreomedical.com/scientific-evidence?hsLang=en)
- [Resources](https://cebreomedical.com/resources?hsLang=en)
- [Contact Us](https://cebreomedical.com/connect-with-our-team?hsLang=en)
- [News](https://cebreomedical.com/news)

# News

# September 2026

*Cebreo™ Medical receives CE mark for NeuroBuds®, a discreet in-ear, medical-grade EEG wearable for extended ambulatory monitoring*

*The Danish medtech company's ear-EEG platform can now be placed on the European market, enabling clinicians to record multi-day and multi-night EEG in the patient's home for epilepsy, sleep and other neurophysiological research and care.*

*Click on the document to the right for the full version*

[![Pressrelease - CE mark 2026](https://cebreomedical.com/hubfs/Pressrelease%20-%20CE%20mark%202026.png "Pressrelease - CE mark 2026")](https://cebreomedical.com/hubfs/News/Cebreo_NeuroBuds_CE_PressRelease_FINAL.pdf?hsLang=en)

![Cebreo Medical - Wordmark white](https://cebreomedical.com/hubfs/Cebreo%20Medical%20-%20Wordmark%20white.svg)

Cebreo Medical A/S  
Borupvang 2  
3450 Lillerød  
Denmark

### Contact Us

© 2025 Company All rights reserved Privacy Policy

[Powered by Atlas - a B2B SaaS HubSpot theme](https://www.kalungi.com/atlas-hubspot-theme-for-b2b-saas-software)